Shivalik Rasayan Ltd submits first US DMF for Bortezomib

Shivalik Rasayan Limited (SRL) has successfully accomplished a major milestone by submitting its first US Drug Master File (DMF) in eCTD format for BORTEZOMIB through ESG gateway to USFDA today.

Shares of Shivalik Rasayan Ltd. was last trading in BSE at Rs. 970 as compared to the previous close of Rs. 995.85. The total number of shares traded during the day was 15785 in over 838 trades.

The stock hit an intraday high of Rs. 1031 and intraday low of 962. The net turnover during the day was Rs. 15585996.

Source : Equity Bulls

Keywords